3695 — GMO Research & AI Share Price
0.000.00%
Last trade - 00:00- ¥5bn
- ¥4bn
- ¥5bn
- 97
- 65
- 24
- 70
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.32 | ||
| Price to Tang. Book | 2.74 | ||
| Price to Free Cashflow | 12.93 | ||
| Price to Sales | 0.91 | ||
| EV to EBITDA | 8.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.08% | ||
| Return on Equity | 13.73% | ||
| Operating Margin | 7.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 3,290.98 | 3,394.93 | 4,086.4 | 5,200.64 | 5,117.2 | n/a | n/a | 9.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -21.04 | +33.84 | +55.39 | +30.01 | -12.1 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GMO Research & AI Inc, formerly GMO Research Inc, is a Japan-based company mainly engaged in the Internet research business, which provides outsourced research, tabulation, and analysis services for market research activities using the Internet. The two main services are outsourcing services, in which it responds to the needs of research firms in Japan, Asia, Europe, and the United States that want the Company to cover all or part of their research needs, and do it yourself (D.I.Y.) services, in which research firms conduct their own research using the Company's platform. The Company also provides other services such as conventional research. The Company is also engaged in the research, planning, development, sales, agency sales, maintenance, operation, and outsourcing of various services that utilize artificial intelligence (AI), event planning, production and management, and worker dispatch business.
Directors
- Tetsuya Hongo MDR (50)
- Takashi Ito MDR (46)
- Kenichiro Ando OTH (40)
- Takenori Mori OTH (44)
- Yusuke Sawada OTH (32)
- Masatoshi Kumagai DRC (58)
- Shinichi Hosokawa DRC (41)
- Tsuneo Orito DRC (50)
- Tetsuya Takano DRC (52)
- Masafumi Yasuda DRC (50)
- Shoji Hashimoto IND (54)
- Hiroaki Yoshida IRC (52)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- April 1st, 2002
- Public Since
- October 21st, 2014
- No. of Shareholders
- 1,367
- No. of Employees
- 187
- Sector
- Media & Publishing
- Industry
- Consumer Cyclicals
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 1,633,856
- Address
- 11F, SHIBUYA-KU, 150-8512
- Web
- https://gmo-research.ai/
- Phone
- +81 359620037
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 3695
Q2 2024 GMO Research & AI Inc Earnings Release
Dividend For 3695.T - 0.0000 JPY
Similar to 3695
Access group Co
Tokyo Stock Exchange
Adways
Tokyo Stock Exchange
AGEHA
Tokyo Stock Exchange
Agile Media Network
Tokyo Stock Exchange
Aidma Marketing Communication
Tokyo Stock Exchange
FAQ
What is the GMO Research & AI share price?
As of Today at 19:09 UTC, shares in GMO Research & AI are trading at ¥2,806. This share price information is delayed by 15 minutes.
How has the GMO Research & AI share price performed this year?
Shares in GMO Research & AI last closed at ¥2,806 and the price had moved by -9.48% over the past 365 days. In terms of relative price strength the GMO Research & AI share price has underperformed the Nikkei 225 Index by -30.75% over the past year.
What are the analyst and broker recommendations for GMO Research & AI?
There is no consensus recommendation for this security.
What is the GMO Research & AI dividend yield?
The GMO Research & AI dividend yield is 4.09% based on the trailing twelve month period.
Does GMO Research & AI pay a dividend?
Last year, GMO Research & AI paid a total dividend of ¥115, and it currently has a trailing dividend yield of 4.09%.Looking ahead, shares in GMO Research & AI are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01.
When does GMO Research & AI next pay dividends?
GMO Research & AI are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01. The historic dividend yield on GMO Research & AI shares is currently 4.09%.
How do I buy GMO Research & AI shares?
To buy shares in GMO Research & AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of GMO Research & AI?
As of the previous close price of ¥2,806, shares in GMO Research & AI had a market capitalisation of ¥5bn.
Where are GMO Research & AI shares listed?
Here are the trading details for GMO Research & AI:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3695
What kind of share is GMO Research & AI?
Based on an overall assessment of its quality, value and momentum GMO Research & AI is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a GMO Research & AI share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the GMO Research & AI share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GMO Research & AI. Over the past six months, its share price has underperformed the Nikkei 225 Index by -14.26%.
As of the last closing price of ¥2,806, shares in GMO Research & AI were trading -1.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the GMO Research & AI PE Ratio?
The GMO Research & AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥2,806.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of GMO Research & AI?
GMO Research & AI's management team is headed by:
- Tetsuya Hongo - MDR
- Takashi Ito - MDR
- Kenichiro Ando - OTH
- Takenori Mori - OTH
- Yusuke Sawada - OTH
- Masatoshi Kumagai - DRC
- Shinichi Hosokawa - DRC
- Tsuneo Orito - DRC
- Tetsuya Takano - DRC
- Masafumi Yasuda - DRC
- Shoji Hashimoto - IND
- Hiroaki Yoshida - IRC